Genmab A/S (GE9.F)

EUR 194.65

(2.93%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 2.2 Billion 1.94 Billion 1.14 Billion 1.35 Billion 718.1 Million 405.38 Million
Cost of Revenue 74.16 Million - - - - -
Gross Profit 2.13 Billion 1.94 Billion 1.14 Billion 1.35 Billion 718.1 Million 405.38 Million
Operating Expenses 1.42 Billion 1.06 Billion 701.08 Million 477.19 Million 346.47 Million 208.66 Million
Selling, General and Administrative Expenses 424.45 Million 343.78 Million 162.7 Million 82.62 Million 45.36 Million 28.4 Million
Research and Development Expenses 997.11 Million 716.79 Million 538.38 Million 394.57 Million 301.1 Million 180.26 Million
Other Expenses - - - - - -
Cost and Expenses 1.49 Billion 1.09 Billion 734.7 Million 510.24 Million 365.07 Million 220.41 Million
Operating Income 713.6 Million 845.37 Million 405.8 Million 848.12 Million 353.02 Million 184.96 Million
Interest Expense 3.62 Million 2.81 Million 1.74 Million 1.34 Million 936.77 Thousand -
Income Tax Expense 172.33 Million 200.18 Million 131.1 Million 153.96 Million 92.74 Million 18.73 Million
Earnings before Tax 755.98 Million 931.19 Million 535.56 Million 793.17 Million 382.6 Million 216.01 Million
Net Income 583.64 Million 731 Million 404.46 Million 639.21 Million 289.86 Million 197.27 Million
Earnings Per Share Basic 8.94 11.18 6.18 9.81 4.60 3.22
Earnings Per Share Diluted 8.85 11.07 6.12 9.70 4.55 3.18
Weighted Average Shares Outstanding 65.3 Million 65.38 Million 65.39 Million 65.17 Million 62.96 Million 61.26 Million
Weighted Average Shares Outstanding (Diluted) 65.91 Million 66 Million 66.04 Million 65.88 Million 63.63 Million 62.04 Million
Gross Margin 0.97 1.00 1.00 1.00 1.00 1.00
EBIT Margin 0.36 0.45 0.39 0.65 0.52 0.49
Profit Margin 0.26 0.38 0.35 0.47 0.40 0.49
EBITDA 803.45 Million 972.89 Million 570.92 Million 827.57 Million 402.14 Million 227.76 Million
Earnings Before Tax Margin 0.32 0.43 0.36 0.62 0.49 0.46

Income Statement Charts